Prelude Capital Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-949
| Closed | -$66K | – | 839 |
|
|
2020
Q3 | $66K | Buy |
949
+22
| +2% | +$1.53K | ﹤0.01% | 796 |
|
|
2020
Q2 | $67K | Buy |
927
+306
| +49% | +$22.1K | ﹤0.01% | 743 |
|
|
2020
Q1 | $29K | Buy |
+621
| New | +$29K | ﹤0.01% | 580 |
|
|
2016
Q3 | – | Sell |
-1,055
| Closed | -$41K | – | 1518 |
|
|
2016
Q2 | $41K | Sell |
1,055
-3,407
| -76% | -$132K | 0.01% | 1026 |
|
|
2016
Q1 | $182K | Sell |
4,462
-3,757
| -46% | -$153K | 0.03% | 524 |
|
|
2015
Q4 | $588K | Buy |
8,219
+1,719
| +26% | +$123K | 0.09% | 214 |
|
|
2015
Q3 | $379K | Sell |
6,500
-29,068
| -82% | -$1.69M | 0.06% | 307 |
|
|
2015
Q2 | $3.22M | Hold |
35,568
| – | – | 0.45% | 31 |
|
|
2015
Q1 | $2.82M | Hold |
35,568
| – | – | 0.39% | 46 |
|
|
2014
Q4 | $2.23M | Buy |
35,568
+640
| +2% | +$40.2K | 0.33% | 40 |
|
|
2014
Q3 | $1.82M | Buy |
34,928
+1,528
| +5% | +$79.4K | 0.26% | 67 |
|
|
2014
Q2 | $1.55M | Buy |
+33,400
| New | +$1.55M | 0.21% | 81 |
|
|
2014
Q1 | – | Sell |
-30,248
| Closed | -$1.14M | – | 1662 |
|
|
2013
Q4 | $1.14M | Buy |
30,248
+16,000
| +112% | +$602K | 0.19% | 102 |
|
|
2013
Q3 | $464K | Buy |
+14,248
| New | +$464K | 0.07% | 274 |
|